fbpx
SATELLITE SYMPOSIUM
barma-charete2
Targeting co-morbidities as a means to personalize heart failure therapy – the 2020 update
Sunday July 12, 2020: 7:00PM – 8:30 PM EEST (GMT +3)
gerasimos -filippatos
GERASIMOS FILIPPATOS
(Greece)
anker
STEFAN ANKER
(Germany)
Faiez Zannad
FAIEZ ZANNAD
(France)
Milton Packer
MILTON PACKER
(USA)
M. Böhm
MICHAEL BÖHM
(Germany)
Chairmen: Gerasimos Filippatos, Stefan Anker
AGENDA:
  • Welcome and introduction – Stefan Anker
  • Chronic kidney disease in Heart Failure – Faiez Zannad
  • Type 2 Diabetes mellitus in Heart Failure – Milton Packer
  • Obesity and Metabolic Syndrome in Heart Failure – Michael Böhm
  • Panel discussion and conclusion – Gerasimos Filippatos
LEARNING OBJECTIVES:
  • Understand the pathophysiology of the cardiorenal syndrome and how optimization of heart failure therapy is key to improved outcomes
  • Understand how insulin resistance and neurohormonal activation are linked both to type-2 diabetes and heart failure and why careful consideration of the choice of agents used to achieve glycemic control is therefore required
  • Examine how components of the metabolic syndrome negatively influence heart failure progression and its implication for treatment strategies
Organised by Charité. Supported by an unrestricted educational grant provided by Boehringer Ingelheim
Looking to register a group of 10 or more? contact: “[email protected]”.

Thank You!